[HTML][HTML] Optimizing therapy for radioactive iodine-refractory differentiated thyroid cancer: current state of the art and future directions
R Dadu, ME Cabanillas - Minerva endocrinologica, 2012 - ncbi.nlm.nih.gov
The majority of patients with differentiated thyroid cancer are cured with standard primary
treatments including surgery, radioactive iodine and TSH suppression. A small proportion of …
treatments including surgery, radioactive iodine and TSH suppression. A small proportion of …
Drug-induced, factitious, & idiopathic diarrhoea
BP Abraham, JH Sellin - Best practice & research Clinical gastroenterology, 2012 - Elsevier
The aetiology of diarrhoea can often be simple to identify, but in some cases may pose a
challenge. The diagnosis of drug-induced diarrhoea can easily be sorted based on timing of …
challenge. The diagnosis of drug-induced diarrhoea can easily be sorted based on timing of …
[HTML][HTML] GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma
JP Spano, Y Vano, S Vignot, T De La Motte Rouge… - Medical Oncology, 2012 - Springer
Abstract Treatment options for radioiodine resistant metastatic thyroid cancer patients are
limited, and chemotherapy is considered an outdated therapeutic method for differentiated …
limited, and chemotherapy is considered an outdated therapeutic method for differentiated …
Vandetanib for the treatment of metastatic medullary thyroid cancer
Medullary thyroid cancer (MTC) represents an aggressive form of thyroid malignancy. Some
may occur spontaneously or can be associated with Multiple Endocrine Neoplasia …
may occur spontaneously or can be associated with Multiple Endocrine Neoplasia …
New Molecular Targeted Therapy and Redifferentiation Therapy for Radioiodine‐Refractory Advanced Papillary Thyroid Carcinoma: Literature Review
Although the majority of papillary thyroid carcinoma could be successfully managed by
complete surgical resection alone or resection followed by radioiodine ablation, a small …
complete surgical resection alone or resection followed by radioiodine ablation, a small …
Steroids and risk of osteonecrosis in ALL: take a break
MM van den Heuvel-Eibrink, R Pieters - The Lancet Oncology, 2012 - thelancet.com
The results of Leonard Mattano and colleagues' report1 in The Lancet Oncology show that
introduction of scheduled breaks from dexamethasone reduces the risk of osteonecrosis in …
introduction of scheduled breaks from dexamethasone reduces the risk of osteonecrosis in …
New insight into the treatment of advanced differentiated thyroid cancer
A Safavi, A Vijayasekaran… - Journal of thyroid …, 2012 - Wiley Online Library
The vast majority of patients with differentiated thyroid cancer (DTC) are treated successfully
with surgery and radioactive iodine ablation, yet the treatment of advanced cases is …
with surgery and radioactive iodine ablation, yet the treatment of advanced cases is …
Treating advanced radioresistant differentiated thyroid cancer
KC Bible - The Lancet Oncology, 2012 - thelancet.com
Despite a decline in overall mortality from cancer in the USA, thyroid cancer incidence has
more than doubled in the past decade, with an associated rise in mortality. 1, 2 Thyroid …
more than doubled in the past decade, with an associated rise in mortality. 1, 2 Thyroid …
[PDF][PDF] Cancers différenciés de la thyroïde: prise en charge et place des nouvelles thérapies ciblées.
T Krahenbuhl, L Portmann, S Anchisi - Revue médicale suisse, 2012 - revmed.ch
Dans 25-30% des cancers thyroïdiens médullaires (CTM), il existe une prédisposition
familiale autosomique dominante soit de type MEN 2A (phéochromocytome (PHEO) et …
familiale autosomique dominante soit de type MEN 2A (phéochromocytome (PHEO) et …
[HTML][HTML] RET: A multi-faceted gene in human cancer
M Santoro, F Carlomagno… - Endocrinology and …, 2012 - synapse.koreamed.org
REarranged during Transfection (RET) gene encodes a receptor tyrosine kinase and it was
initially discovered as an in vitro transforming gene. For many years, RET has been involved …
initially discovered as an in vitro transforming gene. For many years, RET has been involved …